IN2012DN02301A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02301A
IN2012DN02301A IN2301DEN2012A IN2012DN02301A IN 2012DN02301 A IN2012DN02301 A IN 2012DN02301A IN 2301DEN2012 A IN2301DEN2012 A IN 2301DEN2012A IN 2012DN02301 A IN2012DN02301 A IN 2012DN02301A
Authority
IN
India
Prior art keywords
formula
compound
resulting
6alkyl
alkylating
Prior art date
Application number
Other languages
English (en)
Inventor
Augustinus De Kock Herman
Ferdinand Maria Filliers Walter
Albert Alex Aelterman Wim
Original Assignee
Janssen R & D Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland
Publication of IN2012DN02301A publication Critical patent/IN2012DN02301A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN2301DEN2012 2003-09-30 2004-09-30 IN2012DN02301A (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03103630 2003-09-30
US50799603P 2003-10-02 2003-10-02
PCT/EP2004/052382 WO2005030739A1 (en) 2003-09-30 2004-09-30 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
IN2012DN02301A true IN2012DN02301A (cs) 2015-08-14

Family

ID=34395298

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2301DEN2012 IN2012DN02301A (cs) 2003-09-30 2004-09-30

Country Status (24)

Country Link
US (1) US20070123574A1 (cs)
EP (1) EP1670773B1 (cs)
JP (1) JP4919802B2 (cs)
KR (1) KR101090102B1 (cs)
CN (1) CN1860107B (cs)
AP (1) AP1985A (cs)
AT (1) ATE353323T1 (cs)
AU (1) AU2004276017B2 (cs)
BR (1) BRPI0414916A (cs)
CA (1) CA2537877C (cs)
DE (1) DE602004004674T2 (cs)
DK (1) DK1670773T3 (cs)
EA (1) EA011891B1 (cs)
ES (1) ES2281828T3 (cs)
IL (1) IL173891A0 (cs)
IN (1) IN2012DN02301A (cs)
MX (1) MXPA06003575A (cs)
NO (1) NO20061951L (cs)
NZ (1) NZ546279A (cs)
PL (1) PL1670773T3 (cs)
PT (1) PT1670773E (cs)
SI (1) SI1670773T1 (cs)
WO (1) WO2005030739A1 (cs)
ZA (1) ZA200602603B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
WO2011044134A1 (en) * 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
AU2012207335A1 (en) 2011-01-19 2013-07-25 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DK0815124T3 (da) * 1995-03-10 2003-03-17 Searle & Co Heterocyckliske carbonylaminosyre-hydroxyethylamino-sulfonamidinhibitorer af retrovirale proteaser
EP0861249A1 (en) * 1995-11-15 1998-09-02 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6548667B2 (en) * 2000-04-07 2003-04-15 Samsung Electronics Co. Ltd. Sulfonamide derivative as a matrix metalloproteinase inhibitor
US6455738B1 (en) * 2000-07-13 2002-09-24 Rhodia Chimie Process for the sulfonation of an aromatic compound
ES2275866T3 (es) * 2001-02-14 2007-06-16 Tibotec Pharmaceuticals Ltd. 2-(aminosustituido)-benzotiazol-sulfonamidas de amplio esprecto inhibidoras de la proteasa de vih.
EA009590B1 (ru) * 2001-05-11 2008-02-28 Тиботек Фармасьютикалз Лтд. 2-аминобензоксазолсульфонамидные ингибиторы вич-протеазы широкого спектра
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
MY142238A (en) * 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

Also Published As

Publication number Publication date
AP1985A (en) 2009-03-30
BRPI0414916A (pt) 2006-11-07
IL173891A0 (en) 2006-07-05
EA011891B1 (ru) 2009-06-30
DE602004004674D1 (de) 2007-03-22
JP2007507468A (ja) 2007-03-29
EP1670773B1 (en) 2007-02-07
CN1860107A (zh) 2006-11-08
PT1670773E (pt) 2007-05-31
AP2006003603A0 (en) 2006-04-30
KR101090102B1 (ko) 2011-12-07
AU2004276017A1 (en) 2005-04-07
DK1670773T3 (da) 2007-05-29
JP4919802B2 (ja) 2012-04-18
DE602004004674T2 (de) 2007-11-22
CA2537877C (en) 2015-03-17
EA200600699A1 (ru) 2006-08-25
AU2004276017B2 (en) 2010-08-19
ZA200602603B (en) 2008-05-28
KR20060092224A (ko) 2006-08-22
NZ546279A (en) 2008-09-26
WO2005030739A1 (en) 2005-04-07
US20070123574A1 (en) 2007-05-31
ATE353323T1 (de) 2007-02-15
NO20061951L (no) 2006-05-02
SI1670773T1 (sl) 2007-06-30
PL1670773T3 (pl) 2007-06-29
EP1670773A1 (en) 2006-06-21
CA2537877A1 (en) 2005-04-07
CN1860107B (zh) 2013-08-21
MXPA06003575A (es) 2006-06-05
ES2281828T3 (es) 2007-10-01

Similar Documents

Publication Publication Date Title
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
EP0931788A3 (en) Metalloprotease inhibitors
BG103413A (en) Derivatives of sulphinic acid, their production and application
WO2002049641A3 (en) Anti-endoparasitic amidoacetonitrils
WO1999000373A8 (fr) Derives de benzimidazole
NZ505103A (en) Phenylaminoalkylcarboxylic acid derivatives useful as beta 3 adrenoceptor stimulants
IN2012DN02301A (cs)
TW200621685A (en) Hydroxynaphthoic acid hydrazide compound and method for preparing the same
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
BR0009453A (pt) Processo para a preparação de um composto
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
WO2002060878A1 (en) Benzimidazolidinone derivatives
WO2001010861A3 (de) Substituierte heterocyclyl-2h-chromene
WO2004024681A3 (fr) NOUVEAUX COMPOSES COMPRENANT UN GROUPEMENT THIOCARBONYLSULFANYLE UTILES POUR LA SYNTHESE DE COMPOSES α-PERFLUOROALKYLAMINES PAR VOIE RADICALAIRE
AU8459401A (en) Process for preparing a substituted imidazopyridine compound
SE0101323D0 (sv) New process
BR0315508A (pt) Processo para preparação de compostos de pirazol
EP0753514A4 (en) ALKYLENEDIAMINE DERIVATIVES
EP1471058A4 (en) PROCESS FOR PREPARING A 1,2,3-TRIAZOL COMPOUND
SE0000382D0 (sv) New process
WO2001010862A3 (de) Substituierte heterocyclylbenzofurane
CA2390934A1 (en) Process for producing benzylamine compound
TWI256385B (en) Method and intermediate for preparing a prostaglandin f-type compound
AR028729A1 (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas
EP1142892A4 (en) METHOD FOR PRODUCING NEW NAPHTYRIDINE DERIVATIVES